Synthesis of symmetrical 1,5-bis-thio-substituted anthraquinones for cytotoxicity in cultured tumor cells and lipid peroxidation.
暂无分享,去创建一个
J. Chiou | Hsu-Shan Huang | H. Chiu | C. Tao | P. Lin | Jing-Min Hwang | P. Yeh | Wei-Ren Jeng
[1] J. Chiou,et al. Synthesis and Cytotoxicity of 9‐Alkoxy‐1, 5‐dichloroanthracene Derivatives in Murine and Human Cultured Tumor Cells , 2002, Archiv der Pharmazie.
[2] H. Huang,et al. Studies on anthracenes. 3. Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives. , 2001, Chemical and pharmaceutical bulletin.
[3] H. Chiu,et al. Studies on anthracenes. 2. Synthesis and cytotoxic evaluation of 9-acyloxy 1,8-dichloroanthracene derivatives. , 2001, Chemical & pharmaceutical bulletin.
[4] Y. Jen,et al. Studies on anthracenes. 1. Human telomerase inhibition and lipid peroxidation of 9-acyloxy 1,5-dichloroanthracene derivatives. , 2001, Chemical & pharmaceutical bulletin.
[5] F. Chang,et al. Aromin-A, an Annonaceous acetogenin from Annona cherimola. , 1999, Phytochemistry.
[6] G. Capranico,et al. DNA sequence selectivity of topoisomerases and topoisomerase poisons. , 1998, Biochimica et biophysica acta.
[7] E. Uriarte,et al. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. , 1996, Journal of medicinal chemistry.
[8] H. Huang,et al. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis. , 1996, Journal of medicinal chemistry.
[9] C. Teng,et al. N-allylsecoboldine as a novel antioxidant against peroxidative damage. , 1996, European journal of pharmacology.
[10] M. Schara,et al. Reduction of nitroxides by anthralin and some of its derivatives. , 1995, Free Radical Biology & Medicine.
[11] F. Zunino,et al. Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin. , 1994, The Journal of biological chemistry.
[12] F. Zunino,et al. Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavage , 1994, Journal of molecular recognition : JMR.
[13] F. Zunino,et al. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance. , 1994, Molecular pharmacology.
[14] J. Gutteridge,et al. Free radicals in disease processes: a compilation of cause and consequence. , 1993, Free radical research communications.
[15] C. Manzotti,et al. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones. , 1991, Journal of medicinal chemistry.
[16] M. Hacker,et al. Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones. , 1990, Journal of medicinal chemistry.
[17] B. Halliwell,et al. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. , 1986, Archives of biochemistry and biophysics.
[18] P. Gregory,et al. Organic Chemistry in Colour , 1983 .
[19] R. Angier,et al. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones. , 1979, Journal of medicinal chemistry.
[20] R. K. Zee-Cheng,et al. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity. , 1979, Journal of medicinal chemistry.
[21] R. K. Zee-Cheng,et al. Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones. , 1978, Journal of medicinal chemistry.